Infants' Dermal Exposure to Phthalates from Disposable Baby Diapers and Its Association with DNA Oxidative Damage.

Abstract

Phthalates are widely used plasticizers that can leach from consumer products and pose potential health risks, particularly to infants whose developing systems are vulnerable to environmental toxicants. While various exposure pathways have been identified, the contribution of dermal absorption from disposable diapers remains inadequately characterized. This study recruited 66 infants from Guangzhou, a representative city in southern China. Paired disposable diaper and urine samples were collected from each participant. Six phthalates in the diapers and nine metabolites in the urine were quantitatively analyzed. The predominant phthalate detected in the diapers was bis-2-ethylhexyl phthalate (DEHP, with a median concentration of 1670 ng/g, range: 678-5200 ng/g), followed by di-n-butyl phthalate (DnBP, 948 ng/g, range: 189-5980 ng/g), di-iso-butyl phthalate (DiBP, 333 ng/g, range: 16.1-4910 ng/g), and diethyl phthalate (DEP, 252 ng/g, range: 116-3350 ng/g). In urine, metabolites of DEHP (mEHP, mEHHP, and mEOHP) were the most abundant (87.1 ng/mL), followed by mnBP (metabolites of DnBP, 44.6 ng/mL), mEP (metabolites of DEP, 33.7 ng/mL), and miBP (metabolites of DiBP, 13.9 ng/mL). A positive correlation was observed between DnBP levels in diapers and mnBP levels in urine (r = 0.259, p = 0.035). Additionally, several urinary metabolites (miBP, mnBP, and mEP) were positively associated with a biomarker of DNA oxidative damage, 8-hydroxydeoxyguanosine (r = 0.265-0.316, p < 0.01). The estimated daily uptake of DEP, DiBP, DnBP, and DEHP through dermal absorption from diapers accounted for 44.9%, 19.5%, 15.1%, and 7.76% of total exposure to these phthalates, respectively. These findings suggest that dermal absorption from diapers is a significant exposure pathway for infants. Given that both the amount of exposure and the contribution of dermal uptake are higher in younger infants, further attention is warranted to understand the potential effects of transdermal phthalate exposure on infant growth and development.